ProfileGDS4718 / 230641_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 60% 46% 67% 58% 75% 72% 56% 52% 59% 54% 51% 65% 53% 69% 65% 63% 54% 70% 63% 63% 66% 62% 53% 50% 57% 57% 76% 60% 58% 78% 63% 48% 59% 61% 61% 77% 54% 61% 46% 51% 60% 68% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0582559
GSM549102patient 115, normal, homogenized [OPG study]6.1202360
GSM549104patient 119, normal, homogenized [OPG study]5.2878946
GSM549108patient 138, normal, homogenized [OPG study]6.6006967
GSM549119patient 077, normal, homogenized [OPG study]6.0261158
GSM549133patient 032, cancer, homogenized [OPG study]7.400675
GSM549139patient 042, cancer, homogenized [OPG study]7.0356672
GSM549099patient 107, normal, homogenized [OPG study]5.8383456
GSM549109patient 139, normal, homogenized [OPG study]5.6238452
GSM549110patient 046, normal, homogenized [OPG study]6.066259
GSM549114patient 063, normal, homogenized [OPG study]5.686654
GSM549122patient 082, normal, homogenized [OPG study]5.6052951
GSM549134patient 033, cancer, homogenized [OPG study]6.4763465
GSM549136patient 036, cancer, homogenized [OPG study]5.6556153
GSM549140patient 044, cancer, homogenized [OPG study]6.8062169
GSM549111patient 047, normal, homogenized [OPG study]6.5196865
GSM549113patient 057, normal, homogenized [OPG study]6.3151163
GSM549132patient 031, cancer, homogenized [OPG study]5.7187354
GSM549137patient 038, cancer, homogenized [OPG study]6.914370
GSM549142patient 047, cancer, homogenized [OPG study]6.4106463
GSM549100patient 110, normal, homogenized [OPG study]6.3269263
GSM549107patient 135, normal, homogenized [OPG study]6.5663766
GSM549115patient 068, normal, homogenized [OPG study]6.2561962
GSM549116patient 072, normal, homogenized [OPG study]5.6661253
GSM549120patient 078, normal, homogenized [OPG study]5.5162250
GSM549131patient 030, cancer, homogenized [OPG study]5.905557
GSM549118patient 074, normal, homogenized [OPG study]5.9446857
GSM549129patient 027, cancer, homogenized [OPG study]7.5076576
GSM549123patient 088, normal, homogenized [OPG study]6.1167260
GSM549124patient 006, cancer, homogenized [OPG study]6.0101258
GSM549126patient 015, cancer, homogenized [OPG study]7.6017778
GSM549128patient 025, cancer, homogenized [OPG study]6.3509263
GSM549103patient 117, normal, homogenized [OPG study]5.4673248
GSM549117patient 073, normal, homogenized [OPG study]5.9734359
GSM549138patient 041, cancer, homogenized [OPG study]6.2316461
GSM549141patient 045, cancer, homogenized [OPG study]6.1772161
GSM549130patient 028, cancer, homogenized [OPG study]7.5275777
GSM549101patient 111, normal, homogenized [OPG study]5.763154
GSM549105patient 128, normal, homogenized [OPG study]6.1724561
GSM549106patient 134, normal, homogenized [OPG study]5.2673646
GSM549112patient 048, normal, homogenized [OPG study]5.55851
GSM549125patient 011, cancer, homogenized [OPG study]6.0947560
GSM549127patient 024, cancer, homogenized [OPG study]6.7589568
GSM549135patient 035, cancer, homogenized [OPG study]7.5250376